PGF2α induces a pro-labour phenotypical switch in human myometrial cells that can be inhibited with PGF2α receptor antagonists

Preterm birth is the leading cause of infant morbidity and mortality. There has been an interest in developing prostaglandin F2α (PGF2α) antagonists as a new treatment for preterm birth, although much of the rationale for their use is based on studies in rodents where PGF2α initiates labour by regre...

Celý popis

Podrobná bibliografie

Hlavní autoři:	Isabel Hamshaw, Anne Straube, Richard Stark, Laura Baxter, Mohammad T. Alam, Walter J. Wever, Jun Yin, Yong Yue, Philippe Pinton, Aritro Sen, Gregory D. Ferguson, Andrew M. Blanks
Médium:	Artigo
Jazyk:	Inglês
Vydáno:	Frontiers Media S.A. 2023-12-01
Edice:	Frontiers in Pharmacology
Témata:	myometrium PGF2α FP receptor FP antagonists smooth muscle labour
On-line přístup:	https://www.frontiersin.org/articles/10.3389/fphar.2023.1285779/full
Tagy:	Přidat tag Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!